Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.31 |
| ▸ | TTR | P02766 | 1/20 | 0.31 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21133956 | 0.92 | — | — | |
| SCHEMBL21133952 | 0.82 | CYP1A2 (0.31) | CYP1A2CYP2C9HIF1AHSD17B10 | |
| SCHEMBL18290075 | 0.75 | POLB (0.48) | HSD17B10POLBNLRP3TTRTHRA | |
| SCHEMBL27255623 | 0.75 | ELANE (0.39) | POLBNLRP3TTR | |
| SCHEMBL21133955 | 0.74 | — | — | |
| SCHEMBL24667645 | 0.74 | ALDH1A1 (0.31) | — | |
| SCHEMBL25968669 | 0.73 | RIPK1 (0.33) | — | |
| SCHEMBL15625163 | 0.72 | NLRP3 (0.35) | CYP1A2NLRP3 | |
| SCHEMBL21701054 | 0.71 | TTR (0.34) | POLBNLRP3TTRTHRATHRB | |
| SCHEMBL26800387 | 0.70 | POLB (0.38) | HSD17B10POLBNLRP3TTRTHRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10347476-B2 | Tuned synthetic dendrimer calibrants for mass spectrometry | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2019-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10347476-B2 | Tuned synthetic dendrimer calibrants for mass spectrometry | SRMS, SRM, DNMT1 | CYP1A2 3996/4885CYP2C9 3913/4885HIF1A 3765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.